GNI Group Ltd. | Ownership
Companies that own GNI Group Ltd.
FIL Investments (Japan) Ltd.
120,100
0.89%
-38,697
0.04%
03/13/2018
BlackRock Fund Advisors
56,198
0.42%
0
0%
09/06/2018
GO ETF Solutions LLP
25,530
0.19%
25,530
0.04%
02/28/2018
BlackRock Advisors (UK) Ltd.
25,200
0.19%
0
0%
09/06/2018
Siemens Fonds Invest GmbH
11,100
0.08%
300
0.03%
04/30/2018
TIAA-CREF Investment Management LLC
7,600
0.06%
0
0%
03/31/2018
SSgA Funds Management, Inc.
7,300
0.05%
0
0%
09/06/2018
Credit Suisse AG
4,100
0.03%
0
0%
08/31/2018
UBS AG (Investment Management)
3,700
0.03%
0
0%
01/31/2018
The Vanguard Group, Inc.
2,900
0.02%
0
0%
07/31/2018
| Address |
Nihonbashi Honcho YS Bldg., 3/F
Tokyo Tokyo 103
Japan
|
|
Employees
|
- |
| Website |
http://www.gnipharma.com |
| Updated |
07/08/2019 |
| GNI Group Ltd. engages in the development, research, manufacture, and sales of pharmaceutical drugs and traditional Chinese medicines. It operates through Japan and China segments. The Japan segment deals with licensing, preclinical studies, clinical trials, and sales. |
